WEST CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--BTG plc (LSE:BTG), the specialist healthcare company, announced that the U.S. Food and Drug Administration has approved an extension of the post-activation ...
BOTHELL, WA, April 29, 2019 /PRNewswire/ -- BTG plc (LSE: BTG), the global specialist healthcare company, today highlighted the VIEW VLU Registry interim study results, presented at the International ...
FREDERICKSBURG, Texas, Jan. 14, 2020 /PRNewswire-PRWeb/ -- Varicose vein treatment is the latest addition to the medical offerings from board-certified specialist, Robin Fleck, MD, founder and medical ...
BTG plc (LSE: BTG), the specialist healthcare company, today announces that the US Food and Drug Administration (FDA) has approved Varithena(TM) (polidocanol injectable foam) for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results